Vivo Capital Fund VIII, L.P.'s Form 4 filing
Bolt Biotherapeutics, Inc. (BOLT) · filed Nov 20, 2023
- Accession no.
- 0001213900-23-088909
- Filed
- Nov 20, 2023, 9:09 PM ET
- Trade date
- Nov 16-20, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $79.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vivo Capital Fund VIII, L.P.CIK 0001618788 | 10% Owner |
| Vivo Capital VIII, LLCCIK 0001618789 | 10% Owner |
| Vivo Capital Surplus Fund VIII, L.P.CIK 0001628048 | 10% Owner |
| Vivo Panda Fund, L.P.CIK 0001675490 | 10% Owner |
| Vivo Opportunity, LLCCIK 0001728970 | 10% Owner |
| Vivo Panda, LLCCIK 0001843847 | 10% Owner |
| Vivo Opportunity Fund Holdings, L.P.CIK 0001930214 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Common Stock | SSaleDisposed | −7,531 | $0.96 | −$7,229.76 | 1,989,685 | Indirect | |
| Nov 16, 2023 | Common Stock | SSaleDisposed | −1,040 | $0.96 | −$998.4 | 274,749 | Indirect | |
| Nov 16, 2023 | Common Stock | SSaleDisposed | −6,429 | $0.96 | −$6,171.84 | 143,571 | Indirect | |
| Nov 17, 2023 | Comon Stock | SSaleDisposed | −8,211 | $0.93 | −$7,636.23 | 1,981,474 | Indirect | |
| Nov 17, 2023 | Common Stock | SSaleDisposed | −1,134 | $0.93 | −$1,054.62 | 273,615 | Indirect | |
| Nov 17, 2023 | Common Stock | SSaleDisposed | −7,009 | $0.93 | −$6,518.37 | 136,562 | Indirect | |
| Nov 20, 2023 | Common Stock | SSaleDisposed | −27,465 | $0.92 | −$25,267.8 | 1,954,009 | Indirect | |
| Nov 20, 2023 | Common Stock | SSaleDisposed | −3,792 | $0.92 | −$3,488.64 | 269,823 | Indirect | |
| Nov 20, 2023 | Common Stock | SSaleDisposed | −23,443 | $0.92 | −$21,567.56 | 113,119 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.